Nutricog® (Haritaki + Boswellia Cognitive Performance Complex — PLT Health)

Evidence Level
Strong
2 Clinical Trials
7 Documented Benefits
4/5 Evidence Score

Nutricog® is PLT Health Solutions' patented cognitive performance complex — a combination of Haritaki (Terminalia chebula) and Boswellia (Boswellia serrata) standardized to gallic acid, ellagic acid, and amyrins. Five years in development with partner Laila Nutraceuticals. Backed by a 120-day randomized double-blind placebo-controlled trial in 100 healthy adults aged 40-65 using gold-standard cognitive instruments (RAVLT, CANTAB). Significant improvements across learning, memory, sustained attention, working memory, and executive function — with effects on memory and focus starting at just 15 days. Health Canada approved for cognitive health claims.

Studied Dose Per Nutricog clinical trial protocol — daily dosing for 120 days. Effects on memory and focus measurable as early as 15 days; broader cognitive domain effects across 120 days.
Active Compound Patented combination of Haritaki (Terminalia chebula) and Boswellia (Boswellia serrata) — standardized to gallic acid, ellagic acid, and amyrins. Co-developed with Laila Nutraceuticals over 5 years. Both botanicals have extensive Ayurvedic precedent for brain and cognitive applications.

Benefits

Multi-domain cognitive improvement

In the 120-day pivotal trial, Nutricog users demonstrated significant improvements vs placebo across multiple cognitive domains: learning, memory, sustained attention, working memory, and executive function. Few cognitive supplements show effects across this breadth of domains — most target a single area (memory only, or focus only). Broad-spectrum cognitive enhancement is Nutricog's positioning.

Cognitive speed + accuracy simultaneously

In CANTAB testing, Nutricog subjects showed significantly improved Speed of Performance without a reduction in accuracy — meaning faster cognitive processing without the usual speed-accuracy tradeoff. Increases in cognitive speed were seen concurrently with improvements in accuracy while multitasking. Critical for real-world performance where both speed and accuracy matter (work, driving, complex decisions).

Fast 15-day onset

The earliest clinically significant benefits for Nutricog — memory and focus — were shown to start at just 15 days after commencing use. Most cognitive supplements require 4-12 weeks for measurable effects. The 15-day onset is unusually fast for botanical cognitive support, supporting consumer compliance and product positioning.

Working memory and executive function

Working memory (the ability to hold and manipulate information) and executive function (planning, decision-making, multitasking) are the cognitive domains most relevant to everyday task performance. Both improved significantly with Nutricog. These higher-order cognitive functions are particularly valuable to maintain in adults aged 40-65 (the trial population) where natural age-related decline begins.

Validated with gold-standard cognitive instruments

Nutricog clinical effects were measured using RAVLT (Rey Auditory Verbal Learning Test) and CANTAB (Cambridge Neuropsychological Test Automated Battery) — both well-established and validated instruments used in clinical neuropsychology research and pharmaceutical trials. Use of these instruments provides scientific credibility beyond consumer-perception surveys.

Health Canada approval for cognitive claims

PLT received a license from the Natural and Non-Prescription Health Products Directorate (NNHPD) of Health Canada to market Nutricog for cognitive health support in Canada. Health Canada has a high bar for cognitive claims — regulatory approval provides independent validation of the clinical evidence base beyond manufacturer claims.

Quality-of-life multitasking improvements

The Nutricog clinical trial documented improved accuracy while multitasking — directly relevant to modern work and daily life demands. Multitasking under cognitive load is increasingly common in professional and personal contexts. Nutricog's positioning addresses real-world performance demands rather than abstract cognitive measures.

Mechanism of action

1

Gallic acid neuroprotective effects

Gallic acid (one of the Nutricog standardization markers) has documented neuroprotective and antioxidant effects in preclinical research. Reduces oxidative stress in neuronal cells and supports neurotransmitter function. Polyphenolic compounds like gallic acid cross the blood-brain barrier and act directly on central nervous system targets.

2

Ellagic acid antioxidant and anti-inflammatory

Ellagic acid (another standardization marker) has potent antioxidant and anti-inflammatory effects. Brain tissue is particularly vulnerable to oxidative damage due to high metabolic activity and lipid content. Antioxidant support helps preserve cognitive function by reducing neuronal oxidative stress that accumulates with age.

3

Amyrins (Boswellia triterpenes) cognitive effects

Amyrins (α- and β-amyrin) from Boswellia are pentacyclic triterpenes with documented neuroprotective, anti-inflammatory, and anxiolytic-like effects in preclinical research. The 5-LOX inhibition mechanism that supports Boswellia's joint health applications also extends to brain — reducing neuroinflammation that contributes to cognitive decline.

4

Multi-pathway cognitive support synergy

Nutricog combines Haritaki's polyphenolic compounds (gallic acid, ellagic acid) with Boswellia's terpenoid bioactives (amyrins) — different chemical classes addressing complementary cognitive mechanisms. The synergy explains the broad-spectrum effects across multiple cognitive domains vs single-mechanism cognitive supplements.

5

Neuroinflammation reduction

Both component botanicals reduce neuroinflammation through their respective anti-inflammatory pathways. Chronic low-grade neuroinflammation contributes to age-related cognitive decline. Reducing brain inflammation supports the structural and functional integrity of neurons over time — relevant to the cognitive improvements documented across the 40-65 trial population.

Clinical trials

1
Nutricog 120-Day Pivotal RCT — Multi-Domain Cognitive Effects

Randomized double-blind placebo-controlled clinical trial assessing Nutricog for learning, memory, attention, working memory, and decision-making. 120-day intervention. Cognitive assessment via Rey Auditory Verbal Learning Test (RAVLT) and Cambridge Neuropsychological Test Automated Battery (CANTAB) — gold-standard validated cognitive instruments.

100 healthy male and female subjects aged 40-65 years. 120-day intervention.

Nutricog users demonstrated significant improvements vs placebo across multiple cognitive domains: learning, memory, sustained attention, working memory, and executive function. Several CANTAB tests showed significantly improved Speed of Performance without reduction in accuracy — improved cognitive speed concurrent with improved accuracy while multitasking. Earliest clinically significant benefits (memory and focus) started at just 15 days. Foundation for Health Canada cognitive health claim approval.

2
Component Botanical Class Evidence

Independent class evidence for both Nutricog component botanicals in cognitive applications: Terminalia chebula (Haritaki) has Ayurvedic precedent as a Medhya rasayana (cognitive enhancer) plus modern preclinical research; Boswellia serrata has extensive anti-inflammatory clinical trial data with emerging cognitive applications.

Various — preclinical and emerging clinical research on individual component botanicals.

Haritaki has documented neuroprotective effects via gallic acid and ellagic acid in preclinical models. Boswellia's 5-LOX inhibition and anti-inflammatory effects extend to brain tissue and neuroinflammation. The combined Nutricog formulation produces effects beyond either component alone — supporting the multi-pathway synergistic mechanism that distinguishes Nutricog from single-ingredient cognitive supplements.

Side effects and drug interactions

Common Potential side effects

Well-tolerated in the 120-day clinical trial.
Mild GI effects rare.
Boswellia may have mild blood-thinning effects — relevant before surgery.
Pregnancy and lactation: avoid. Boswellia has traditional contraindications in pregnancy.
Long-term safety supported by extensive Ayurvedic use of both component botanicals spanning millennia.
Health Canada approval supports the safety and efficacy of cognitive health claims.

Important Drug interactions

Anticoagulants (warfarin, DOACs) and antiplatelets (aspirin, clopidogrel) — Boswellia may have mild antiplatelet effects; monitor INR with warfarin.
Leukotriene modifiers (montelukast) — same 5-LOX pathway as Boswellia; theoretical additive effect.
Cognitive medications (cholinesterase inhibitors, NMDA antagonists) — different mechanisms; consult prescriber before combining.
ADHD stimulants — different mechanisms; minimal interaction concern but consult prescriber.
Diabetes medications — Haritaki may have mild glucose-modulating effects; monitor blood glucose.
Pregnancy and lactation: avoid.

Frequently asked questions about Nutricog® (Haritaki + Boswellia Cognitive Performance Complex — PLT Health)

What is Nutricog?

Nutricog® is PLT Health Solutions' patented cognitive performance complex — a combination of Haritaki (Terminalia chebula) and Boswellia (Boswellia serrata) standardized to gallic acid, ellagic acid, and amyrins. Five years in development with partner Laila Nutraceuticals.

What is Nutricog used for?

Nutricog is researched primarily for Cognitive. In the 120-day pivotal trial, Nutricog users demonstrated significant improvements vs placebo across multiple cognitive domains: learning, memory, sustained attention, working memory, and executive function.

What is the recommended dosage of Nutricog?

The clinically studied dose is Per Nutricog clinical trial protocol — daily dosing for 120 days. Effects on memory and focus measurable as early as 15 days; broader cognitive domain effects across 120 days. Always follow the product label and check with a healthcare provider for personal advice.

Is Nutricog safe, and does it have side effects?

For most healthy adults, Nutricog is well tolerated at studied doses. Reported effects can include: Well-tolerated in the 120-day clinical trial. Mild GI effects rare. It may also interact with some medications. Nutricog is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Nutricog interact with any medications?

Possible interactions include: Anticoagulants (warfarin, DOACs) and antiplatelets (aspirin, clopidogrel) — Boswellia may have mild antiplatelet effects; monitor INR with warfarin. Leukotriene modifiers (montelukast) — same 5-LOX pathway as Boswellia; theoretical additive effect. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Nutricog?

NutraSmarts rates the evidence for Nutricog as Strong (4 out of 5). It is backed by 2 clinical trials and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Salter D, Gupta SVB, Sairam B, Gupta AK, Maurya R. A standardized combination of Boswellia serrata and Terminalia chebula extracts to improve cognition in adults with subjective memory complaints: a randomized controlled proof-of-concept study. Front Nutr. 2025;12:1695341. doi: 10.3389/fnut.2025.1695341.PubMedUsed to support: The Nutricog brand RCT (LN19184, n=100 adults 40-65 with subjective memory complaints, 300 mg/day for 120 days) reported significant improvements over placebo in RAVLT learning/memory, CANTAB visual learning and processing speed, sleep, and serum BDNF; it is a small single-site proof-of-concept study by the manufacturer, so industry-funded and needs independent replication.
  2. Pingali U, Sukumaran D, Nutalapati C. Effect of an aqueous extract of Terminalia chebula on endothelial dysfunction, systemic inflammation, and lipid profile in type 2 diabetes mellitus: A randomized double-blind, placebo-controlled clinical study. Phytother Res. 2020;34(12):3226-3235. doi: 10.1002/ptr.6771.PubMedUsed to support: Human RCT (n=60 type 2 diabetics, 250/500 mg twice daily for 12 weeks) finding Terminalia chebula reduced oxidative-stress and inflammation biomarkers and improved endothelial function versus placebo, supporting the antioxidant rationale for the Haritaki component; a small disease-population trial that does not measure cognition directly.
  3. Khazani H, Jalali Kondori B, Sahraei H, Meftahi GH. Terminalia chebula attenuates restraint stress-induced memory impairment and synaptic loss in the dentate gyrus of the hippocampus and the basolateral and central nuclei of the amygdala by inhibiting oxidative damage. Brain Res Bull. 2024;213:110975. doi: 10.1016/j.brainresbull.2024.110975.PubMedUsed to support: An animal (rat) study, not a human trial: Terminalia chebula reversed stress-induced memory impairment and hippocampal/amygdala synaptic loss by reducing oxidative damage, providing only preclinical mechanistic support for the memory/antioxidant claim.